Geode Capital Management’s Kindred Biosciences, Inc. KIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-435,705
Closed -$4M 4911
2021
Q2
$4M Sell
435,705
-262,494
-38% -$2.41M ﹤0.01% 3035
2021
Q1
$3.47M Buy
698,199
+78,219
+13% +$389K ﹤0.01% 2961
2020
Q4
$2.67M Buy
619,980
+1,727
+0.3% +$7.44K ﹤0.01% 2920
2020
Q3
$2.65M Buy
618,253
+19,466
+3% +$83.5K ﹤0.01% 2732
2020
Q2
$2.69M Buy
598,787
+59,481
+11% +$267K ﹤0.01% 2682
2020
Q1
$2.16M Buy
539,306
+67,259
+14% +$269K ﹤0.01% 2630
2019
Q4
$4M Buy
472,047
+15,379
+3% +$130K ﹤0.01% 2593
2019
Q3
$3.13M Buy
456,668
+25,829
+6% +$177K ﹤0.01% 2667
2019
Q2
$3.59M Buy
430,839
+34,896
+9% +$291K ﹤0.01% 2600
2019
Q1
$3.63M Buy
395,943
+56,299
+17% +$516K ﹤0.01% 2509
2018
Q4
$3.72M Buy
339,644
+5,233
+2% +$57.3K ﹤0.01% 2405
2018
Q3
$4.67M Buy
334,411
+52,685
+19% +$735K ﹤0.01% 2395
2018
Q2
$3M Buy
281,726
+70,298
+33% +$749K ﹤0.01% 2613
2018
Q1
$1.83M Buy
211,428
+4,530
+2% +$39.2K ﹤0.01% 2820
2017
Q4
$1.96M Sell
206,898
-889
-0.4% -$8.4K ﹤0.01% 2763
2017
Q3
$1.63M Buy
207,787
+69,725
+51% +$547K ﹤0.01% 2858
2017
Q2
$1.19M Buy
138,062
+69,037
+100% +$594K ﹤0.01% 3032
2017
Q1
$486K Buy
69,025
+4,081
+6% +$28.7K ﹤0.01% 3320
2016
Q4
$276K Buy
64,944
+300
+0.5% +$1.28K ﹤0.01% 3490
2016
Q3
$321K Buy
64,644
+75
+0.1% +$372 ﹤0.01% 3440
2016
Q2
$228K Hold
64,569
﹤0.01% 3542
2016
Q1
$222 Sell
64,569
-75
-0.1% ﹤0.01% 3598
2015
Q4
$219K Buy
64,644
+150
+0.2% +$508 ﹤0.01% 3649
2015
Q3
$335K Buy
64,494
+3,865
+6% +$20.1K ﹤0.01% 3431
2015
Q2
$413K Sell
60,629
-7,252
-11% -$49.4K ﹤0.01% 3284
2015
Q1
$484K Sell
67,881
-9,912
-13% -$70.7K ﹤0.01% 3209
2014
Q4
$579K Buy
77,793
+10,362
+15% +$77.1K ﹤0.01% 3120
2014
Q3
$623K Sell
67,431
-5,149
-7% -$47.6K ﹤0.01% 3059
2014
Q2
$1.35M Buy
72,580
+25,638
+55% +$478K ﹤0.01% 2614
2014
Q1
$869K Buy
+46,942
New +$869K ﹤0.01% 2872